On 10 October 2010, Autumn Eagle entered into various sale and purchase agreements (“SPAs”) with seven vendors in total whereby the vendors agreed to sell and Autumn Eagle agreed to purchase, on the terms and conditions set out in the SPAs, 319,312,200 issued ordinary shares in the capital of Biosensors (the “Sale Shares”), representing approximately 29.47 per cent. of the issued share capital of Biosensors. The consideration for the Sale Shares was arrived at after taking into account the average price of the shares of Biosensors traded for the 45-day period prior to the date of the SPAs.
Tencent bounces back: What to know about China’s tech giant
-
About Tencent (SGX: HTCD): A Global Leader in Digital Services Established
in 1998, Tencent has become one of the most recognised companies in China
and ...
9 hours ago
No comments:
Post a Comment